Metabolomics Market Size to Hit USD 14.40 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Metabolomics Market

5.1. COVID-19 Landscape: Metabolomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Metabolomics Market, By Product & Service

8.1. Metabolomics Market Revenue and Volume, by Product & Service

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Bioinformatics Tools & Services

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Metabolomics Services

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Metabolomics Market, By Application

9.1. Metabolomics Market Revenue and Volume, by Application

9.1.1. Biomarker Discovery

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Drug Discovery & Development

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Personalized Medicine

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Clinical Diagnostics

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Toxicology Testing

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Nutrigenomics & Functional Genomics

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Agriculture & Environmental Research

9.1.7.1. Market Revenue and Volume Forecast

9.1.8. Others

9.1.8.1. Market Revenue and Volume Forecast

Chapter 10. Global Metabolomics Market, By Study Type

10.1. Metabolomics Market Revenue and Volume, by Study Type

10.1.1. Targeted Metabolomics

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Untargeted Metabolomics

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Semi-targeted Metabolomics

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Metabolomics Market, By Indication

11.1. Metabolomics Market Revenue and Volume, by Indication

11.1.1. Oncology

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Neurology

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Cardiovascular Diseases

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Metabolic Disorders

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Infectious Diseases

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Metabolomics Market, By End User

12.1. Metabolomics Market Revenue and Volume, by End User

12.1.1. Pharmaceutical & Biotechnology Companies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Academic & Research Institutes

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Diagnostic Laboratories

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Contract Research Organizations (CROs)

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Food & Agriculture Industry

12.1.5.1. Market Revenue and Volume Forecast

12.1.6. Others

12.1.6.1. Market Revenue and Volume Forecast

Chapter 13. Global Metabolomics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product & Service

13.1.2. Market Revenue and Volume Forecast, by Application

13.1.3. Market Revenue and Volume Forecast, by Study Type

13.1.4. Market Revenue and Volume Forecast, by Indication

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product & Service

13.1.6.2. Market Revenue and Volume Forecast, by Application

13.1.6.3. Market Revenue and Volume Forecast, by Study Type

13.1.6.4. Market Revenue and Volume Forecast, by Indication

13.1.6.5. Market Revenue and Volume Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product & Service

13.1.7.2. Market Revenue and Volume Forecast, by Application

13.1.7.3. Market Revenue and Volume Forecast, by Study Type

13.1.7.4. Market Revenue and Volume Forecast, by Indication

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product & Service

13.2.2. Market Revenue and Volume Forecast, by Application

13.2.3. Market Revenue and Volume Forecast, by Study Type

13.2.4. Market Revenue and Volume Forecast, by Indication

13.2.5. Market Revenue and Volume Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product & Service

13.2.6.2. Market Revenue and Volume Forecast, by Application

13.2.6.3. Market Revenue and Volume Forecast, by Study Type

13.2.7. Market Revenue and Volume Forecast, by Indication

13.2.8. Market Revenue and Volume Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product & Service

13.2.9.2. Market Revenue and Volume Forecast, by Application

13.2.9.3. Market Revenue and Volume Forecast, by Study Type

13.2.10. Market Revenue and Volume Forecast, by Indication

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product & Service

13.2.12.2. Market Revenue and Volume Forecast, by Application

13.2.12.3. Market Revenue and Volume Forecast, by Study Type

13.2.12.4. Market Revenue and Volume Forecast, by Indication

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product & Service

13.2.14.2. Market Revenue and Volume Forecast, by Application

13.2.14.3. Market Revenue and Volume Forecast, by Study Type

13.2.14.4. Market Revenue and Volume Forecast, by Indication

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product & Service

13.3.2. Market Revenue and Volume Forecast, by Application

13.3.3. Market Revenue and Volume Forecast, by Study Type

13.3.4. Market Revenue and Volume Forecast, by Indication

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product & Service

13.3.6.2. Market Revenue and Volume Forecast, by Application

13.3.6.3. Market Revenue and Volume Forecast, by Study Type

13.3.6.4. Market Revenue and Volume Forecast, by Indication

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product & Service

13.3.8.2. Market Revenue and Volume Forecast, by Application

13.3.8.3. Market Revenue and Volume Forecast, by Study Type

13.3.8.4. Market Revenue and Volume Forecast, by Indication

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product & Service

13.3.10.2. Market Revenue and Volume Forecast, by Application

13.3.10.3. Market Revenue and Volume Forecast, by Study Type

13.3.10.4. Market Revenue and Volume Forecast, by Indication

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product & Service

13.3.11.2. Market Revenue and Volume Forecast, by Application

13.3.11.3. Market Revenue and Volume Forecast, by Study Type

13.3.11.4. Market Revenue and Volume Forecast, by Indication

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product & Service

13.4.2. Market Revenue and Volume Forecast, by Application

13.4.3. Market Revenue and Volume Forecast, by Study Type

13.4.4. Market Revenue and Volume Forecast, by Indication

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product & Service

13.4.6.2. Market Revenue and Volume Forecast, by Application

13.4.6.3. Market Revenue and Volume Forecast, by Study Type

13.4.6.4. Market Revenue and Volume Forecast, by Indication

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product & Service

13.4.8.2. Market Revenue and Volume Forecast, by Application

13.4.8.3. Market Revenue and Volume Forecast, by Study Type

13.4.8.4. Market Revenue and Volume Forecast, by Indication

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product & Service

13.4.10.2. Market Revenue and Volume Forecast, by Application

13.4.10.3. Market Revenue and Volume Forecast, by Study Type

13.4.10.4. Market Revenue and Volume Forecast, by Indication

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product & Service

13.4.11.2. Market Revenue and Volume Forecast, by Application

13.4.11.3. Market Revenue and Volume Forecast, by Study Type

13.4.11.4. Market Revenue and Volume Forecast, by Indication

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product & Service

13.5.2. Market Revenue and Volume Forecast, by Application

13.5.3. Market Revenue and Volume Forecast, by Study Type

13.5.4. Market Revenue and Volume Forecast, by Indication

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product & Service

13.5.6.2. Market Revenue and Volume Forecast, by Application

13.5.6.3. Market Revenue and Volume Forecast, by Study Type

13.5.6.4. Market Revenue and Volume Forecast, by Indication

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product & Service

13.5.8.2. Market Revenue and Volume Forecast, by Application

13.5.8.3. Market Revenue and Volume Forecast, by Study Type

13.5.8.4. Market Revenue and Volume Forecast, by Indication

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Agilent Technologies, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Thermo Fisher Scientific Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Bruker Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Abbott

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Waters Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Shimadzu Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Danaher Corporation (Sciex)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. PerkinElmer, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Bio-Rad Laboratories, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Metabolon, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The metabolomics market size is expected to increase from USD 3.77 billion in 2024 to USD 14.40 billion by 2034.

The metabolomics market is expected to grow at a compound annual growth rate (CAGR) of around 14.34% from 2025 to 2034.

The major players in the metabolomics market include Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bruker Corporation, Waters Corporation, Shimadzu Corporation, Danaher Corporation (Sciex), PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Metabolon, Inc., Human Metabolome Technologies, Inc., LECO Corporation, Creative Proteomics, Chenomx Inc., Biocrates Life Sciences AG, Owlstone Medical Ltd., MetaboAnalyst, Evotec SE, Seoul National University R&DB Foundation, Metabolomic Discoveries GmbH, and NIHS Metabolomics Core.

The driving factors of the metabolomics market are the rising emphasis on precision medicine.

North America region will lead the global metabolomics market during the forecast period 2025 to 2034.